Research programme: peptide vaccines - CYTLIMIC
Latest Information Update: 03 Jan 2017
At a glance
- Originator NEC Corporation; Yamaguchi University
- Class Cancer vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 21 Dec 2016 Early research in Cancer in Japan (unspecified route)